Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) rose 0.8% on Friday. The stock traded as high as $1.35 and last traded at $1.32. Approximately 137,500 shares traded hands during mid-day trading, an increase of 576% from the average session volume of 20,327 shares. The stock had previously closed at $1.31.
ImmunoPrecise Antibodies Stock Up 0.8%
The stock has a fifty day moving average price of $1.36 and a 200-day moving average price of $1.40.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Holdings Inc is a biotechnology company that provides antibody discovery and development services to pharmaceutical, biotechnology and academic research organizations. Through its operations in Canada and other jurisdictions, the company supports projects ranging from early-stage target research and antibody generation to optimization and preclinical development.
The company develops monoclonal and polyclonal antibodies, recombinant proteins and related research reagents.
Featured Articles
- Five stocks we like better than ImmunoPrecise Antibodies
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
